BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 6710050)

  • 1. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
    Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the circulating immune complexes in acute and chronic liver diseases.
    Schena FP; Pastore G; Pastore A; Angarano G; Meliconi L; Schiraldi O; Bonomo L
    J Clin Lab Immunol; 1983 Apr; 10(4):179-83. PubMed ID: 6864764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen.
    Sagnelli E; Felaco FM; Triolo G; Vernace SJ; Filippini P; Piccinino F; Behrens U; Paronetto F
    J Clin Lab Immunol; 1983 Sep; 12(1):11-5. PubMed ID: 6195340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
    Coursaget P; Barres JL; Tortey E; Cotty P; Diop T; Yvonnet B; Sow MT; Mboup S; Diop B; Bocande JE
    Cancer Res; 1986 Mar; 46(3):1492-4. PubMed ID: 3943106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
    Araki K; Nagashima H; Tsuji T
    Clin Exp Immunol; 1982 Mar; 47(3):520-6. PubMed ID: 6282506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Course control and significance of circulating HBsAg-specific immune complexes in acute viral hepatitis B].
    Markus R; Baumgarten R; Fengler JD; Richter H; Apostoloff E
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(4):229-42. PubMed ID: 3803280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating acid-labile interferon in chronic versus acute, HBV-related liver disease. A marker of immune-mediated hepatocellular damage?
    Biglino A; Cariti G; Gioannini P
    Boll Ist Sieroter Milan; 1985; 64(3):201-6. PubMed ID: 2412572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early prognostic significance of hepatitis B surface antigen specific circulating immune complexes in acute type B viral hepatitis].
    Markus R
    Z Gesamte Inn Med; 1990 Oct; 45(20):623-5. PubMed ID: 2099582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of cryoglobulinemia in a series of cases of chronic liver diseases].
    Ruggiero G; Spadacenta F; Gargiulo M; Miraglia E; Gianturco G
    Minerva Med; 1979 Sep; 70(42):2863-7. PubMed ID: 492553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in hepatitis B: levels, immunoglobulin class of antibody and the presence of hepatitis B surface antigen.
    Brown SE; Howard CR; Steward MW; Viola L; Murray-Lyon IM
    Dev Biol Stand; 1983; 54():391-7. PubMed ID: 6653894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for circulating immune complexes in blood donors as an effective method of further HBsAg carriers detection.
    Pintera J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):455-61. PubMed ID: 6169608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating HBsAg/IgM complexes in acute and chronic hepatitis B.
    Musca A; Cordova C; Barnaba V; Zaccari C; Levrero M; van Dyke A; Balsano F
    Hepatogastroenterology; 1984 Oct; 31(5):208-10. PubMed ID: 6510881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
    Anh-Tuan N; Novák E
    Clin Exp Immunol; 1981 Feb; 43(2):246-53. PubMed ID: 7273479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune complex levels and HBs-antigenaemia in healthy Nigerians and patients with liver diseases.
    Okerengwo AA; Atoba MA
    Afr J Med Med Sci; 1992 Dec; 21(2):35-8. PubMed ID: 1308079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological studies in HBV-related chronic liver diseases.
    Joshi N; Ayesha Q; Habibullah CM
    Indian J Pathol Microbiol; 1990 Oct; 33(4):351-4. PubMed ID: 2132503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulating immune complexes in patients with acute and chronic diseases of the liver].
    Uibo RM; Nutt HR; Prjukk TJ
    Ter Arkh; 1989; 61(2):61-4. PubMed ID: 2524905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes in HBsAg-positive and HBsAg-negative chronic liver diseases.
    Pastore G; Schena FP; Angarano G; Monno L; Santantonio T; Pertosa G; Schiraldi O
    Ric Clin Lab; 1984; 14(1):29-35. PubMed ID: 6427879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic reactivity of the skin in chronic hepatitis].
    Fuchs H
    Ann Acad Med Stetin; 1990; 36():61-75. PubMed ID: 2099109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis.
    Gupta RC
    Clin Exp Immunol; 1982 Sep; 49(3):543-51. PubMed ID: 7172494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoenzyme analysis of antigen-specific determination of HBsAG-containing circulating immune complexes (CIC HBsAG/IgM and CIC HBsAG/IgG) in blood serum of patients with HBV-infection].
    Sokolenko AA; Shakhanina KL; Kurilov AN
    Biull Eksp Biol Med; 1992 Feb; 113(2):174-6. PubMed ID: 1377044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.